T. Muraleedharan, K. Ammineni, P. Shah, and Srijamya, “Residual Inflammatory Risk in Atherosclerotic Cardiovascular Disease: Is Anti-Inflammatory Therapy the Next Frontier Beyond LDL Reduction?”, Int J Med Stud, Aug. 2026.